bruker - BRKR
BRKR
Close Chg Chg %
64.34 -1.50 -2.33%
Closed Market
62.84
-1.50 (2.33%)
Volume: 1.73M
Last Updated:
Jul 31, 2026, 4:00 PM EDT
Company Overview: bruker - BRKR
BRKR Key Data
| Open $64.66 | Day Range 61.26 - 65.30 |
| 52 Week Range 28.53 - 64.54 | Market Cap $8.86B |
| Shares Outstanding 152.23M | Public Float 111.11M |
| Beta 1.29 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.24 |
| Yield 32.39% | Dividend $0.05 |
| EX-DIVIDEND DATE Jun 22, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.03M |
BRKR Performance
| 1 Week | 6.44% | ||
| 1 Month | 4.38% | ||
| 3 Months | 74.88% | ||
| 1 Year | 69.36% | ||
| 5 Years | -21.78% |
BRKR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
14
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 59.75 | |
| Number of Ratings | 14 | Current Quarters Estimate | 0.552 | |
| FY Report Date | 09 / 2026 | Current Year's Estimate | 2.121 | |
| Last Quarter’s Earnings | 0.383 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.83 | Next Fiscal Year Estimate | 2.429 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 13 | 13 | 14 | 14 |
| Mean Estimate | 0.55 | 0.87 | 2.12 | 2.43 |
| High Estimates | 0.57 | 0.89 | 2.14 | 2.62 |
| Low Estimate | 0.54 | 0.85 | 2.10 | 2.32 |
| Coefficient of Variance | 2.00 | 1.42 | 0.58 | 3.31 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 7 | 7 | 8 |
| OVERWEIGHT | 2 | 2 | 1 |
| HOLD | 4 | 4 | 6 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 1 | 1 | 1 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Bruker - BRKR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Bruker - BRKR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 19, 2026 | William Alderman Linton Director | 63,243 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 19, 2026 | Thomas Bures Chief Accounting Officer | 3,198 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $36.51 per share | 116,758.98 |
| Feb 19, 2026 | Cynthia M. Friend Director | 22,536 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 19, 2026 | Jack Phillips Director | 4,520 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 19, 2026 | Bonnie H. Anderson Director | 17,847 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 19, 2026 | Hermann Fritz Requardt Director | 30,965 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 19, 2026 | Adelene Q. Perkins Director | 29,144 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 19, 2026 | Laura A. Francis Director | 9,018 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 19, 2026 | Richard A. Packer Director | 93,694 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 19, 2026 | Robert J. Rosenthal Director | 38,781 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 19, 2026 | Mark Robert Munch EXEC VP&PRES BRUKER NANO INC. | 14,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 19, 2026 | Mark Robert Munch EXEC VP&PRES BRUKER NANO INC. | 128,443 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $36.94 per share | 4,744,684.42 |
| Feb 19, 2026 | Mark Robert Munch EXEC VP&PRES BRUKER NANO INC. | 130,443 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $22.19 per share | 2,894,530.17 |
| Feb 19, 2026 | John A. Ornell Director | 39,732 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Aug 13, 2025 | Frank H. Laukien PRESIDENT & CEO; Director | 38,455,167 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.43 per share | 1,170,190,731.81 |
| Aug 13, 2025 | Frank H. Laukien PRESIDENT & CEO; Director | 38,450,510 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.43 per share | 1,170,049,019.30 |
| Aug 13, 2025 | Frank H. Laukien PRESIDENT & CEO; Director | 38,445,672 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.78 per share | 1,183,357,784.16 |
| Aug 13, 2025 | Gerald N. Herman EXECUTIVE VICE PRESIDENT, CFO | 76,739 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.78 per share | 2,362,026.42 |
| Aug 13, 2025 | Gerald N. Herman EXECUTIVE VICE PRESIDENT, CFO | 78,159 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.43 per share | 2,378,378.37 |
| Aug 13, 2025 | Gerald N. Herman EXECUTIVE VICE PRESIDENT, CFO | 79,539 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.43 per share | 2,420,371.77 |